Related Experiment Video
Updated: Oct 2, 2025
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Jeffrey W Tyner1,2, Franziska Haderk3,4,5, Anbarasu Kumaraswamy6
1Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Abstract:
Decades of research into the molecular mechanisms of cancer and the development of novel therapeutics have yielded a number of remarkable successes. However, our ability to broadly assign effective, rationally targeted therapies in a personalized manner remains elusive for many patients, and drug resistance persists as a major problem. This is in part due to the well-documented heterogeneity of cancer, including the diversity of tumor cell lineages and cell states, the spectrum of somatic mutations, the complexity of microenvironments, and immune-suppressive features and immune repertoires, which collectively require numerous different therapeutic approaches. Here, we describe a framework to understand the types and biological causes of resistance, providing translational opportunities to tackle drug resistance by rational therapeutic strategies.
Insights
Cancer drug resistance remains a major challenge due to tumor heterogeneity. This study presents a framework to understand resistance mechanisms, offering new strategies for developing effective, personalized cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Despite advances in cancer molecular mechanisms and therapeutics, personalized treatment assignment remains challenging.
- Drug resistance is a significant problem in cancer treatment, limiting therapeutic efficacy for many patients.
- Cancer's inherent heterogeneity, encompassing cellular diversity, mutations, microenvironments, and immune interactions, complicates treatment strategies.
Purpose of the Study:
- To describe a framework for understanding the types and biological causes of cancer drug resistance.
- To identify translational opportunities for developing rational therapeutic strategies to overcome drug resistance.
Main Methods:
- Review and synthesis of existing research on cancer heterogeneity and drug resistance mechanisms.
- Development of a conceptual framework categorizing resistance types and their biological underpinnings.
Main Results:
- Identification of key factors contributing to cancer drug resistance, including cellular diversity, somatic mutations, and immune microenvironments.
- Establishment of a framework linking specific resistance mechanisms to potential therapeutic interventions.
Conclusions:
- A deeper understanding of cancer heterogeneity is crucial for tackling drug resistance.
- The proposed framework provides a basis for designing rational, personalized therapeutic strategies to improve patient outcomes.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Related Concept Videos
02:56Treatment Resistant Cancers
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:21Cancer Survival Analysis
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...